Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.

Icon's balance sheet is sound, with its revenue cyclicality and operating leverage each possessing a medium rating. Icon has historically maintained a fairly conservative balance sheet, and it ended ...

A team has discovered how certain bacteria breathe by generating electricity, using a natural process that pushes electrons into their surroundings instead of breathing on oxygen. The findings could ...

The BioScience Alliance in Westlake Village, Ventura County’s 2nd District, the Economic Development Collaborative and India’s Atal Incubation Centre have entered into an agreement aimed at ...

The result has spurred a nationwide data privacy debate, which includes an upcoming May 6 Congressional hearing focused on ...

New Haven-based Arvinas will lay off 131 employees, with 92 in Connecticut, as part of a major workforce reduction.

While it was generally assumed that the return to power of business-friendly President Donald Trump would help facilitate M&A ...

Arizona’s bioscience industry continues to grow, and in some cases, that growth is happening at a faster rate than the rest ...

With the walls quickly closing in, Kronos Bio has accepted a buyout from notorious biotech acquirer Concentra Biosciences. | With the walls quickly closing in, Kronos Bio has accepted a buyout from ...

A team led by Rice University bioscientist Caroline Ajo-Franklin has discovered how certain bacteria breathe by generating ...

Biotech leaders at a Stanford symposium normally focused on the future couldn’t help but grapple with a present clouded by ...

Eascra's proprietary technology, pioneered by co-founder Dr. Yupeng Chen, can deliver RNA therapeutics to hard-to-reach ...